Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Neoplasms, Plasma Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Melphalan 5Dexamethasone 4Bortezomib 3Arsenic Trioxide 3fludarabine phosphate 2Vorinostat 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Drug Therapy 2Busulfan 2Ascorbic Acid 2ogalvibart 1ethanolamine oleate 1daratumumab 1crexavibart 1carfilzomib 1Zoledronic Acid 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Thalidomide 1Tacrolimus 1Surveys and Questionnaires 1Sulfamethoxazole 1Sodium Chloride 1Simvastatin 1Saline Solution, Hypertonic 1Saline Solution 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms, Plasma Cell × Blood Component Removal × Clear all
NCT00968396 2013-04-05

Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡